Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aryl hydrocarbon receptor nuclear translocator (ARNT), also known as hypoxia-inducible factor 1-beta (HIF-1β), is a basic helix-loop-helix-PAS transcription factor that serves as an obligate dimerization partner for several key transcription factors, including HIF-1α, HIF-2α, and the aryl hydrocarbon receptor (AhR). In response to hypoxia or environmental toxins, ARNT forms active heterodimeric complexes that translocate to the nucleus and bind to specific DNA response elements, driving the transcription of genes involved in angiogenesis, glycolysis, cell survival, and xenobiotic metabolism. In clear cell renal cell carcinoma (ccRCC), loss of the von Hippel-Lindau (VHL) tumor suppressor leads to constitutive activation of the HIF pathway, making ARNT a critical therapeutic target. Historically considered difficult to target with small molecules due to its role as a transcription factor scaffold, ARNT is now being targeted by novel therapeutics such as NEO-811, a clinical-stage molecular glue degrader that recruits the CRL4-CRBN E3 ubiquitin ligase to induce proteasomal degradation of ARNT, thereby comprehensively shutting down oncogenic HIF and AhR signaling.
Targeted protein degradation via cereblon-mediated ubiquitination and proteasomal degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aryl hydrocarbon receptor nuclear translocator (ARNT) (ARNT).